- PLN61.22m
- PLN76.16m
- PLN53.88m
- 77
- 36
- 59
- 61
Annual balance sheet for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.4 | 3.01 | 12.9 | 1.5 | 0.909 |
| Net Total Receivables | 8.55 | 16.5 | 10.5 | 8.56 | 11 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 25.4 | 33.5 | 36.2 | 22.8 | 25.4 |
| Net Property, Plant And Equipment | 21.7 | 27.9 | 37.8 | 50.6 | 50.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 47.7 | 61.9 | 74.4 | 73.8 | 76.3 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.1 | 17.3 | 11 | 10.4 | 17.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 27.8 | 32.7 | 22 | 26.8 | 29 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 19.9 | 29.2 | 52.5 | 47 | 47.3 |
| Total Liabilities & Shareholders' Equity | 47.7 | 61.9 | 74.4 | 73.8 | 76.3 |
| Total Common Shares Outstanding |